RFA-IP-25-111: Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues
Closed
This grant is closed. A newer notice from the same program is forecast: Informing global polio eradication efforts through innovative modeling approaches (CDC-RFA-JG-27-0077). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2024.
Centers for Disease Control and Prevention - ERA offered grants of up to $750,000 (at least $400,000) to nonprofits, colleges and universities, state and local governments and tribes. It expected to make one award worth $3.8 million in total. Applications closed on February 6, 2025.
From the official notice on Grants.gov, last changed December 4, 2024. Checked November 7, 2026.
- Award ceiling$750,000
- Award floor$400,000
- Total funding$3.8 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 4, 2024 |
|---|---|
| Deadline | February 6, 2025 |
| Archived by Grants.gov | March 7, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
All 13 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
N/A
Is this a realistic fit?
- Past Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects awards averaged $3.5 million; this notice allows up to $750,000 per award.
- Most of the program's money (47% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity (NOFO) is to support a research project to obtain timely input from nationally representative samples of healthcare providers and of the public on critical immunization issues of importance to public health. The objectives of this NOFO are: (1) to conduct multiple surveys of healthcare providers and the public each year of the period of performance to collect immunization-related data using scientifically sound methods with adequate response rates that produce generalizable results, and (2) to disseminate these results broadly to assist in informing recommendations for new vaccines, developing strategies to improve immunization coverage, and instituting contingency plans to address urgent problems (e.g., vaccine supply shortages). Surveyed healthcare providers should include at a minimum: pediatricians, family physicians, obstetrician/gynecologists, general internists, and pharmacists. Surveyed members of the public should be at least 18 years old and should include subpopulations of special interest for consideration of immunization-related issues such as pregnant women, parents of children aged 0-5 years, and persons with chronic medical conditions.
Who has won Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects grants before
From fiscal 2021 to 2025, Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects (93.185) awarded $857 million across 243 grant awards, an average of $3.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Unicef | New York | 2 | $133 million |
| National Foundation for the Centers for Disease Control & Prevention, Inc. | Georgia | 2 | $74.7 million |
| Community Catalyst Inc | Massachusetts | 1 | $39.4 million |
| Pan American Health Organization | District of Columbia | 3 | $21.9 million |
| Unidosus | District of Columbia | 1 | $18.6 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0077, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-IP-25-111 still open?
No. It closed on February 6, 2025. A newer notice is forecast: CDC-RFA-JG-27-0077, expected deadline February 12, 2027.
Who can apply for Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues?
Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues?
Closed February 6, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each. About $3.8 million in total for one award.
Who has won Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects grants before?
The largest recipients over five fiscal years were Unicef, National Foundation for the Centers for Disease Control & Prevention, Inc., Community Catalyst Inc. The program made 243 awards worth $857 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)